The novel, radiopaque, polymer-based embolic coil from Embolization, Inc., is demonstrating consistent success in its limited-market release, with use cases topping 70 coils.
Embolization, Inc. announced findings from the limited-market release of the company’s nitinol enhanced device (NED), which ...
Penumbra has announced US Food and Drug Administration approval for its Ruby XL system, which includes three coils: the Ruby XL, the POD XL and the Packing Coil XL. The Ruby XL coil is a device used ...
One of the key drivers of the detachable embolization coils market is the rapid shift toward minimally invasive endovascular therapies. Interventional neuroradiology and vascular surgery departments ...
Newark, Feb. 21, 2023 (GLOBE NEWSWIRE) -- The brainy Insights estimates that the USD 1,200 million in 2022 embolization coils market will reach USD 1,772 million by 2030. The main drivers driving the ...
Market in North America region to propel the highest growth The Neurology segment to garner the highest growth Market in Europe region to grow at the highest rate Growing Preference for Minimally ...
You’re healthy, active and life is good. Then, you start having pain behind your eyes, frequent killer headaches and difficulty with your vision and balance. You shake it off as nothing, but you ...
Intracranial aneurysms are small balloon-like dilated portions of blood vessels that may occasionally rupture, causing haemorrhage, stroke or death. Usually, the cause is unknown but people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results